Patents by Inventor Elizabeth Zaretsky

Elizabeth Zaretsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polypeptides Having Endoglucanase Activity And Polynucleotides Encoding Same
    Publication number: 20120023626
    Abstract: The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: October 5, 2011
    Publication date: January 26, 2012
    Applicants: NOVOZYMES, INC., NOVOZYMES A/S
    Inventors: Paul Harris, Elena Vlasenko, Elizabeth Zaretsky, Marcus Sakari Kauppinnen, Sarah Teter, Kimberly Brown
  • Polypeptides having endoglucanase activity and polynucleotides encoding same
    Patent number: 8080386
    Abstract: The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: March 30, 2007
    Date of Patent: December 20, 2011
    Assignees: Novozymes, Inc., Novozymes A/S
    Inventors: Paul Harris, Elena Vlasenko, Elizabeth Zaretsky, Marcus Sakari Kauppinnen
  • Polypeptides having endoglucanase activity and polynucleotides encoding same
    Patent number: 8063267
    Abstract: The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: March 30, 2007
    Date of Patent: November 22, 2011
    Assignees: Novozymes, Inc., Novozymes A/S
    Inventors: Paul Harris, Elena Vlasenko, Marcus Sakari Kauppinnen, Elizabeth Zaretsky, Sarah Teter, Kimberly Brown
  • Polypeptides having endoglucanase activity and polynucleotides encoding same
    Publication number: 20110185454
    Abstract: The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: March 30, 2006
    Publication date: July 28, 2011
    Applicants: Novozymes A/S, Novozymes, Inc.
    Inventors: Paul Harris, Elena Vlasenko, Elizabeth Zaretsky, Marcus Sakari Kauppinnen
  • Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same
    Publication number: 20100197556
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: April 14, 2010
    Publication date: August 5, 2010
    Applicant: NOVOZYMES, INC.
    Inventors: KIMBERLY BROWN, PAUL HARRIS, ELIZABETH ZARETSKY, EDWARD RE, ELENA VLASENKO, KEITH MCFARLAND, ALFREDO LOPEZ DE LEON
  • Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same
    Patent number: 7741466
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: March 21, 2008
    Date of Patent: June 22, 2010
    Assignee: Novozymes, Inc.
    Inventors: Kimberly Brown, Paul Harris, Elizabeth Zaretsky, Edward Re, Elena Vlasenko, Keith McFarland, Alfredo Lopez de Leon
  • Polypeptides having endoglucanase activity and polynucleotides encoding same
    Publication number: 20090328259
    Abstract: The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: March 30, 2007
    Publication date: December 31, 2009
    Applicants: Novozymes A/S, Novozymes ,INC.
    Inventors: Paul Harris, Elena Vlasenko, Elizabeth Zaretsky, Marcus Sakari Kauppinnen, Sarah Teter, Kimberly Brown
  • Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same
    Publication number: 20080206815
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: March 21, 2008
    Publication date: August 28, 2008
    Applicant: NOVOZYMES, INC.
    Inventors: Kimberly Brown, Paul Harris, Elizabeth Zaretsky, Edward Re, Elena Vlasenko, Keith McFarland, Alfredo Lopez de Leon
  • Polypeptide from a cellulolytic fungus having cellulolytic enhancing activity
    Patent number: 7361495
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: January 28, 2005
    Date of Patent: April 22, 2008
    Assignee: Novozymes, Inc.
    Inventors: Kimberly Brown, Paul Harris, Elizabeth Zaretsky, Edward Re, Elena Vlasenko, Keith McFarland, Alfredo Lopez de Leon
  • Polypeptides having xyloglucanase activity and nucleic acids encoding same
    Publication number: 20060110797
    Abstract: The present invention relates to isolated polypeptides having Family 74 xyloglucanase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: December 6, 2005
    Publication date: May 25, 2006
    Applicant: Novozymes, Inc.
    Inventors: Michael Rey, Elizabeth Zaretsky, Jeffrey Haas
  • Polypeptides having cellulolytic enhancing activity andpolynucleotides encoding same
    Publication number: 20050191736
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: January 28, 2005
    Publication date: September 1, 2005
    Applicant: Novozymes Biotech, Inc.
    Inventors: Kimberly Brown, Paul Harris, Elizabeth Zaretsky, Edward Re, Elena Vlasenko, Keith McFarland, Alfredo Lopez de Leon
  • Microbial trypsin mutants having chymotrypsin activity and nucleic acids encoding same
    Publication number: 20050037368
    Abstract: The present invention relates to microbial trypsin variants having chymotrypsin-like activity, comprising: (a) a one or more substitutions corresponding to positions 144, S193A, 198, 201, 218, 223, 227, 228, 229, 230, and 231 of amino acids 25 to 248 of SEQ ID NO: 2, (b) one or more deletions corresponding to positions 192, 197, and 226 of amino acids 25 to 248 of SEQ ID NO: 2; and (c) an insertion between positions corresponding to positions 224 and 225 of amino acids 25 to 248 of SEQ ID NO: 2. The present invention further relates to nucleotide sequences encoding microbial trypsin variants having chymotrypsin-like activity; nucleic acid constructs, expression vectors, and recombinant host cells comprising such nucleotide sequences; and methods of producing microbial trypsin variants having chymotrypsin-like activity or a precursor thereof.
    Type: Application
    Filed: September 24, 2003
    Publication date: February 17, 2005
    Applicant: Novozymes Biotech, Inc.
    Inventors: Alan Klotz, Kimberly Brown, Elizabeth Zaretsky